News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Aduro Clean Technologies advances HCT validation and commercial partnerships, prompting a catalysts-driven swing trade to $18.50 from $14.26.
  • ADUR trade plan: buy at $14.26, target $18.50, stop $12.50, with near-term test and FOAK logistics catalysts.
  • Analysts flag execution, regulatory and dilution risks for ADUR that could derail the catalysts-led rally.
  • Applied Industrial shows resilient fundamentals and cash generation but trades near 52-week highs on a stretched PE around 31.
  • Recommendation for Applied Industrial is to wait for a measured pullback before buying to avoid overhead risk.
  • Catalyst-focused small-cap trades look attractive, but stretched valuations increase risk of broader pullbacks for risk assets.

Latest Articles

Beyond Meat® Launches Beyond Immerse™ in New York

Beyond Meat® Launches Beyond Immerse™ in New York

Beyond Meat, Inc. (NASDAQ: BYND) has introduced its first functional beverage line, Beyond Immerse, in the New York metro area through a strategic partnership with leading beverage distributor Big Geyser. The launch features plant-based protein, fiber, antioxidants, and electrolytes in a light, sparkling drink available in three flavors. Pro basket…

Serve Robotics Continues Expansion Beyond Food Delivery, Launches Autonomous Laundry Vertical with NoScrubs

Serve Robotics Continues Expansion Beyond Food Delivery, Launches Autonomous Laundry Vertical with NoScrubs

Serve Robotics Inc. announces a strategic partnership with NoScrubs to launch a pilot program delivering laundry using Serve's existing fleet of autonomous robots in Los Angeles. This marks Serve's entry into a new urban delivery vertical beyond prepared food, leveraging the growing online laundry services market. The partnership aims to increase r…

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

Beta Bionics announced the launch of a public dashboard featuring near real-time real-world data on the performance of its iLet Bionic Pancreas automated insulin delivery system. This initiative aims to provide clinicians, patients, and payers with transparent, continuously updated outcomes data for all iLet users meeting simple inclusion criteria,…

USA Rare Earth Selects Cherokee County, South Carolina for New Rare Earth Metal and Magnet Manufacturing Operation

USA Rare Earth Selects Cherokee County, South Carolina for New Rare Earth Metal and Magnet Manufacturing Operation

USA Rare Earth has selected Cherokee County, South Carolina, for a new magnet manufacturing and rare earth metals operation, expected to create approximately 490 high-wage jobs. This $1.2 billion investment will expand the company's domestic production capacity of neodymium-iron-boron permanent magnets and heavy rare earth metals to 10,000 metric t…

Morningstar Pegs SpaceX at $780 Billion, Well Below Company IPO Goal

Morningstar Pegs SpaceX at $780 Billion, Well Below Company IPO Goal

Morningstar's appraisal places SpaceX at $780 billion, substantially lower than the $1.75 trillion valuation the company is targeting for its upcoming IPO. The research house singled out uncertainties around SpaceX's artificial intelligence initiatives, including xAI and X, and noted technological and competitive risks for Starlink and proposed orb…

BCA: Improving macro picture should keep dollar firm in near term

BCA: Improving macro picture should keep dollar firm in near term

BCA Research says the dollar's muted reaction during the Iran-related tensions reflects a retreat in geopolitical risk premia rather than an erosion of confidence in the currency. With risk sentiment improving and interest-rate and growth dynamics set to favor the U.S., the research house expects the dollar to remain resilient over the coming quart…

Morningstar Pegs SpaceX at $780 Billion, Far Below Company's IPO Goal

Morningstar Pegs SpaceX at $780 Billion, Far Below Company's IPO Goal

Morningstar values SpaceX at $780 billion, substantially lower than the company's stated IPO target. The research firm questioned the economics and competitive position of SpaceX's AI initiatives and highlighted technological and external risks for Starlink. Despite near-term upside driven by low float and heavyweight underwriters, Morningstar caut…

Buy-the-Dip Trade on Alphabet After $80B Raise — Why A Small Dilution Doesn’t Break The AI Thesis

Buy-the-Dip Trade on Alphabet After $80B Raise — Why A Small Dilution Doesn’t Break The AI Thesis

Alphabet announced an $80 billion multi-tiered equity raise to fund AI infrastructure. That headline sparked a near-term pullback. The math shows the raise implies roughly a 1.8% dilution if fully executed at current prices — small relative to Alphabet’s $4.5 trillion market cap and $64.4 billion in free cash flow. This trade idea buys the pullback…

RenX Posts Record Delivery Quarter at Myakka City, Up 57%; Independent Drone Survey Verifies Approximately 185,000 Cubic Yards On-Site

RenX Posts Record Delivery Quarter at Myakka City, Up 57%; Independent Drone Survey Verifies Approximately 185,000 Cubic Yards On-Site

RenX Enterprises Corp. announced a record delivery quarter at its Myakka City, Florida facility, with a 57% increase in finished mulch, compost, and wood products compared to the prior quarter. An independent drone survey verified approximately 185,000 cubic yards of material on-site, supporting their operational scale. RenX emphasizes its technolo…

Cleveland Fed’s Hammack Flags Possible Rate Hikes if Inflation Remains Elevated

Cleveland Fed’s Hammack Flags Possible Rate Hikes if Inflation Remains Elevated

Federal Reserve Bank of Cleveland President Beth Hammack warned that continued inflationary pressures could prompt the Federal Reserve to raise interest rates if current trends persist. Speaking at the City Club of Cleveland, Hammack emphasized that inflation risks have grown and that waiting for conclusive evidence of entrenched inflation could fo…

Genius Group Completes First Investments for its AI Treasury with Pre-IPO exposure to SpaceX, Anthropic and OpenAI

Genius Group Completes First Investments for its AI Treasury with Pre-IPO exposure to SpaceX, Anthropic and OpenAI

Genius Group has commenced deployment of its AI Treasury strategy by investing approximately $657,100 across funds with exposure to leading pre-IPO frontier AI and technology companies such as Anthropic, SpaceX, and OpenAI. This marks the first phase of a planned $100 million, multi-month dollar-cost averaging program within a targeted $800 million…

Buy Ambarella on a Strategic Pullback - A Mid-Term Edge-AI Trade

Buy Ambarella on a Strategic Pullback - A Mid-Term Edge-AI Trade

Ambarella is not trying to be NVIDIA. It designs low-power vision SoCs for cameras, robotics, ADAS and industrial automation - markets where on-device AI and power-efficiency matter. With record fiscal 2026 revenue of $390.7M (up 37% YoY), AI chips now 80% of sales, and a new 4nm CV7 SoC announced at CES 2026, the stock offers a mid-term trade: buy…

Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML

Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML

Kura Oncology and Kyowa Kirin announced publication in the journal Blood of updated Phase 1a/b trial results of KOMZIFTI (ziftomenib) combined with venetoclax and azacitidine in patients with relapsed/refractory NPM1-mutated AML. The combination demonstrated high response rates, deep molecular remissions, and a manageable safety profile, particular…